Abstract 5548: Single-cell transcriptome analysis reveals the role of myofibroblastic cancer-associated fibroblasts in chemotherapy resistance in pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer types often diagnosed late due to lack of specific biomarkers and its high capacity to metastasize early. In PDAC, tumor microenvironment (TME) is particularly complex, representing up to 80% of the tumor mass. Thus, better understanding of the cellular states and their controlling transcriptional networks within both malignant and stromal cells is pertinent to improve the survival of PDAC patients. The goal of this project is to elucidate the dynamic non-genetic regulatory mechanisms that contribute to PDAC progression and development of chemoresistance. We have performed in-silico analysis of single-cell RNA-sequencing data from >200,000 cells derived from pancreatic cancer patients with and without neoadjuvant treatment. Based on their gene expression profiles, we identified 12 distinct cell types including three major fibroblast subtypes: regular cancer-associated fibroblasts (CAF), inflammatory CAFs (iCAF), and myofibroblastic CAFs (myCAF). We found that tumors from patients with poor treatment response as well as from untreated patients exhibited a higher proportion of myCAFs compared to treatment-responsive patients. Using specific markers derived from each fibroblast subtype, we applied these signatures to the PAAD cohort from TCGA and found a significant association between the myCAF signature and worse prognosis as well as advanced TNM staging. Functional analyses further demonstrated elevated levels of Wnt/β-Catenin and Notch signaling pathways in the untreated and poor-response groups. Second, we utilized state-of-the-art machine learning methods to model robust relations between transcription factors (TF) and gene regulatory networks from treatment-naïve and neoadjuvant-treated PDAC patients. Our analysis revealed both well-known and new TFs related to pancreatic cell identity and PDAC progression. In-silico perturbation of these TFs was performed to study their effect on gene expression and cell state dynamics. The predictions reported a strong activity from both well-known and newly predicted TFs regarding the cell state transitions and their regulatory role. Currently, we are further characterizing the identified cell states and associated transcriptional programs, and the findings will be presented in the meeting. Citation Format: Jiahao Guo, Samuele Cancellieri, Liangru Fei, Tero Aittokallio, Biswajyoti Sahu. Single-cell transcriptome analysis reveals the role of myofibroblastic cancer-associated fibroblasts in chemotherapy resistance in pancreatic cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5548.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-5548
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 5548: Single-cell transcriptome analysis reveals the role of myofibroblastic cancer-associated fibroblasts in chemotherapy resistance in pancreatic cancer

Liangru Fei, Tero A. Aittokallio, Biswajyoti Sahu, Jiahao Guo et al.
Cancer Research
Pancreatic and Hepatic Oncology Research
article

Abstract 5548: Single-cell transcriptome analysis reveals the role of myofibroblastic cancer-associated fibroblasts in chemotherapy resistance in pancreatic cancer

Liangru Fei, Tero A. Aittokallio, Biswajyoti Sahu, Jiahao Guo, Samuele Cancellieri
article en

Abstract

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer types often diagnosed late due to lack of specific biomarkers and its high capacity to metastasize early. In PDAC, tumor microenvironment (TME) is particularly complex, representing up to 80% of the tumor mass. Thus, better understanding of the cellular states and their controlling transcriptional networks within both malignant and stromal cells is pertinent to improve the survival of PDAC patients. The goal of this project is to elucidate the dynamic non-genetic regulatory mechanisms that contribute to PDAC progression and development of chemoresistance. We have performed in-silico analysis of single-cell RNA-sequencing data from >200,000 cells derived from pancreatic cancer patients with and without neoadjuvant treatment. Based on their gene expression profiles, we identified 12 distinct cell types including three major fibroblast subtypes: regular cancer-associated fibroblasts (CAF), inflammatory CAFs (iCAF), and myofibroblastic CAFs (myCAF). We found that tumors from patients with poor treatment response as well as from untreated patients exhibited a higher proportion of myCAFs compared to treatment-responsive patients. Using specific markers derived from each fibroblast subtype, we applied these signatures to the PAAD cohort from TCGA and found a significant association between the myCAF signature and worse prognosis as well as advanced TNM staging. Functional analyses further demonstrated elevated levels of Wnt/β-Catenin and Notch signaling pathways in the untreated and poor-response groups. Second, we utilized state-of-the-art machine learning methods to model robust relations between transcription factors (TF) and gene regulatory networks from treatment-naïve and neoadjuvant-treated PDAC patients. Our analysis revealed both well-known and new TFs related to pancreatic cell identity and PDAC progression. In-silico perturbation of these TFs was performed to study their effect on gene expression and cell state dynamics. The predictions reported a strong activity from both well-known and newly predicted TFs regarding the cell state transitions and their regulatory role. Currently, we are further characterizing the identified cell states and associated transcriptional programs, and the findings will be presented in the meeting. Citation Format: Jiahao Guo, Samuele Cancellieri, Liangru Fei, Tero Aittokallio, Biswajyoti Sahu. Single-cell transcriptome analysis reveals the role of myofibroblastic cancer-associated fibroblasts in chemotherapy resistance in pancreatic cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5548.

Cancer ResearchVol. 85(8_Supplement_1)
Oslo University Hospital (NO), University of Oslo (NO)
Openalex Percentile: Top 88%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.